Current News

Contact | Print version | PDF version | Send article | RSS-Feed

Qbiogene becomes part of MP Biomedicals

27 Sep 2004 - MP Biomedicals (formerly ICN Biomedicals) is pleased to announce the acquisition of Qbiogene creating a single world-class biomedical organization with the merger of life science and diagnostics product offerings. With the inclusion of Qbiogene products and expertise, MP Biomedicals has expanded its industry leading portfolio of products and solutions, and will continue to provide scientists and researchers with innovative tools and superior service.
 
MP Biomedicals is a global corporation headquartered in Irvine, California. MP Biomedicals has operations in Northern California, New York, Ohio, Japan (Tokyo), Belgium (Brussels), Germany (Eschwege), Australia (Seven Hills), Russia (Moscow) and Singapore. Now with the addition of Qbiogene, MP Biomedicals will also have offices in France (Strasbourg), Canada (Montreal) and Carlsbad, California. For more information, visit www.mpbio.com or www.qbiogene.com.